Luca Cindolo

Dr. Luca Cindolo, MD and PhD, is an italian urologist, who dedicated his professional life in urooncology both on clinical, surgical and biological ground, and in lower urinary tract dysfunction with a great attention to the surgical relief of the bladder output obstruction. With his >250 peer rewiewed papers published (h-index = 58), in the last 2 decades he participated as principal investigator and coinvestigator in several clinical trials being familial with the Good Clinical Practices. After a long period in the National Health system, where he reached the position of the Chief of the Robotic Unit of “SS. Annunziata” Hospital in Chieti , nowadays he’s the Chief of the Urology Dept. of the Villa Stuart Private Hospital in Rome and cofounder of the “Centro Urologico Europeo” (CURE Group) . He has served in multiple roles with the Italian Urological Society (SIU) and is currently active member of the Research Office of the same society. He acts as reviewer in several peer reviewed journals (e.g. European Urology, Urology, Int Journal of Urology and Nephrology, Minerva Urology and Nephrology,, Urology Annals, PLoS One, etc). From January 2022 he will serve Associate Editor for Prostate Cancer and Prostatic Diseases. His principal research interests recently lie with minimally invasive surgical treatments for benign prostatic hyperplasia (Green Laser, Rezūm, iTind, Optilume) and pharmacological therapy of prostate cancer. He is also active in medical education and is the coordinator of periodic medical writing courses. He is a medical graduate of the University of Naples IT, continued his training with a residency in Urology in University of Naples IT. He was trained in urological surgery through several the training programmes across Europe (France, Germany, Spain). He concluded a PhD programme in Translational Medicine at the University of Chieti, IT.